Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Clinical symptoms predict poor overall survival in chronic-dialysis patients with renal cell carcinoma associated with end-stage renal disease.

Ikezawa E, Kondo T, Hashimoto Y, Kobayashi H, Iizuka J, Takagi T, Omae K, Tanabe K.

Jpn J Clin Oncol. 2014 Nov;44(11):1096-100. doi: 10.1093/jjco/hyu117. Epub 2014 Aug 19.

PMID:
25139162
2.

Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.

Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Eur Urol. 2013 Oct;64(4):600-6. doi: 10.1016/j.eururo.2012.12.023. Epub 2012 Dec 25.

PMID:
23280319
3.

The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.

Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.

J Urol. 2002 Jul;168(1):56-60.

PMID:
12050492
4.

Renal cell carcinoma: prognostic significance of incidentally detected tumors.

Tsui KH, Shvarts O, Smith RB, Figlin R, de Kernion JB, Belldegrun A.

J Urol. 2000 Feb;163(2):426-30.

PMID:
10647646
5.

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A.

J Urol. 2000 Apr;163(4):1090-5; quiz 1295.

PMID:
10737472
6.

Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.

Pan D, Xu L, Liu H, Zhang W, Zhu Y, Xu J, Gu J.

Jpn J Clin Oncol. 2015 Feb;45(2):202-9. doi: 10.1093/jjco/hyu194. Epub 2014 Nov 23.

PMID:
25420690
7.

Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.

Yoo C, Song C, Hong JH, Kim CS, Ahn H.

J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.

PMID:
18550101
8.
9.

Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.

Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG.

J Urol. 2007 Nov;178(5):1896-900. Epub 2007 Sep 17.

PMID:
17868729
10.

Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.

Kawaciuk I, Hyrsl L, Dusek P, Jarolim L, Schmidt M, Kaliska V, Chocholaty M, Vesely S.

Scand J Urol Nephrol. 2008;42(5):406-11. doi: 10.1080/00365590802022151.

PMID:
18932106
11.

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulié M, Kleinclauss F, Badet L, Patard JJ; Comité de Transplantation de l'Association Française d'Urologie; Comité de Cancérologie de l'Association Française d'Urologie.

Eur Urol. 2011 Aug;60(2):366-73. doi: 10.1016/j.eururo.2011.02.035. Epub 2011 Mar 2.

PMID:
21377780
12.

Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.

Takagi T, Kondo T, Izuka J, Kobayashi H, Tomita E, Hashimoto Y, Tanabe K.

Int J Urol. 2011 Dec;18(12):806-12. doi: 10.1111/j.1442-2042.2011.02852.x. Epub 2011 Sep 14.

13.

Overall mortality after radical nephrectomy in patients aged over 80 years with renal cancer: a retrospective study on preoperative prognostic factors.

Brassart E, Lebdai S, Berger J, Traore S, Bernhard JC, Fardoun T, Muller G, Patard JJ, Azzouzi AR, Bigot P.

Int J Urol. 2012 Jul;19(7):626-32. doi: 10.1111/j.1442-2042.2012.03006.x. Epub 2012 Mar 27.

14.

The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).

Linder BJ, Thompson RH, Leibovich BC, Cheville JC, Lohse CM, Gastineau DA, Boorjian SA.

BJU Int. 2014 Sep;114(3):368-74. doi: 10.1111/bju.12535. Epub 2014 Jan 29.

15.

[Prognostic value of venous tumor thrombus in renal cell carcinoma].

García-Fadrique G, Budía-Alba A, Ruiz-Cerdá JL, Morales-Solchaga G, Pontones JL, Jiménez-Cruz JF.

Actas Urol Esp. 2012 Jan;36(1):29-34. doi: 10.1016/j.acuro.2011.06.002. Epub 2011 Jul 30. Spanish.

PMID:
21802784
16.

Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.

Wagner B, Patard JJ, Méjean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valéri A, Meyer N, Jacqmin D, Lang H.

Eur Urol. 2009 Feb;55(2):452-9. doi: 10.1016/j.eururo.2008.07.053. Epub 2008 Aug 5.

PMID:
18692951
17.

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.

Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.

J Urol. 2001 Jul;166(1):68-72.

PMID:
11435825
18.

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).

Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V; Members of the CORONA project and the SATURN project.

Eur Urol. 2013 Sep;64(3):472-7. doi: 10.1016/j.eururo.2012.06.030. Epub 2012 Jun 22.

PMID:
22748912
19.

Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?

Gigante M, Neuzillet Y, Patard JJ, Tillou X, Thuret R, Branchereau J, Timsit MO, Terrier N, Boutin JM, Sallusto F, Karam G, Barrou B, Chevallier D, Mazzola CR, Delaporte V, Doeffler A, Kleinclauss F, Badet L; members of the Comité de Cancerologie de l'Association Française d'Urologie (CCAFU); Comité de Transplantation de l'Association Française d'Urologie (CTAFU).

BJU Int. 2012 Dec;110(11 Pt B):E570-3. doi: 10.1111/j.1464-410X.2012.11273.x. Epub 2012 Jun 22.

20.

Incidental detection beyond pathological factors as prognostic predictor of renal cell carcinoma.

Ficarra V, Prayer-Galetti T, Novella G, Bratti E, Maffei N, Dal Bianco M, Artibani W, Pagano F.

Eur Urol. 2003 Jun;43(6):663-9.

PMID:
12767368

Supplemental Content

Support Center